| 1 |
33805347 | 5-Aza-2'-Deoxycytidine and Valproic Acid in Combination with CHIR99021 and A83-01 Induce Pluripotency Genes Expression in Human Adult Somatic Cells. | 2021 Mar 29 |
1 |
| 2 |
29943354 | VPA selectively regulates pluripotency gene expression on donor cell and improve SCNT embryo development. | 2018 Aug |
1 |
| 3 |
30509303 | HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy. | 2018 Dec 3 |
1 |
| 4 |
28153093 | Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency. | 2017 Feb 1 |
1 |
| 5 |
25232932 | Identification of small activating RNAs that enhance endogenous OCT4 expression in human mesenchymal stem cells. | 2015 Feb 1 |
1 |
| 6 |
25826722 | Prolonged proteasome inhibition cyclically upregulates Oct3/4 and Nanog gene expression, but reduces induced pluripotent stem cell colony formation. | 2015 Apr |
4 |
| 7 |
24361750 | Valproic acid enhances Oct4 promoter activity through PI3K/Akt/mTOR pathway activated nuclear receptors. | 2014 Mar 5 |
1 |
| 8 |
23050522 | Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics. | 2013 Feb 1 |
1 |
| 9 |
22387464 | Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers. | 2012 Jul |
1 |
| 10 |
22860916 | HDAC1/DNMT3A-containing complex is associated with suppression of Oct4 in cervical cancer cells. | 2012 Aug |
2 |
| 11 |
20564199 | Valproic acid enhances Oct4 promoter activity in myogenic cells. | 2010 Jul 1 |
1 |
| 12 |
18568017 | Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. | 2008 Jul |
2 |
| 13 |
18849973 | Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. | 2008 Nov |
2 |